Qinecsa Highlights - February 2025
Qinecsa CEO Discusses The Outlook for The Life Sciences Industry in 2025
Qinecsa Solutions' CEO, Adam Sherlock sat down with Pharmaceutical-Technology to discuss the outlook for the life sciences industry in 2025, focusing in on an increased scrutiny of the cost of health globally, the mega trend of AI and the potential implication for a much broader range of conditions, diseases, and treatment areas using GLP.
Upcoming Webinar | 18 February 2025
Revolutionizing Literature Screening:
Challenges, Innovations, and Future Trends
Don't miss out! Join expert Dr Preeti Verma for a dynamic 30-minute session on the latest in pharmacovigilance literature screening. Explore industry challenges, AI and automation, and emerging trends, with a Q&A to wrap up and address your specific questions. Choose from 3 convenient time slots.
Why is Reportum the Leading Digital-First Intake Tool for PV?
When reporting an adverse event, shouldn’t people have the right tool to ensure their efforts produce high-quality data and strengthen safety profiles? Watch below to see how Reportum streamlines pharmacovigilance processes for pharma of all sizes.
领英推荐
Article: Predictions for Clinical Research in 2025?
Martin Holm-Petersen , Qinecsa’s Chief Technology & Innovation Officer, is featured in Clinical Research News ' Trendspotting: Predictions for Clinical Research in 2025. Martin shares his vision on how AI-driven adverse event platforms are revolutionizing pharmacovigilance, enhancing efficiency and patient focus in clinical trials.
Case Study: Standardizing Safety Data Collection with Reportum
Discover why Qinecsa's Reportum platform is the leading digital-first intake tool for Patient Support Programs (PSP), by standardizing safety data collection across vendors and regions.
Article: The Industry's AI Future
Martin Holm-Petersen contributes to PharmaVoice 's 2025 AI Trends feature, highlighting how working with various AI/ML models is critical in leveraging technology to transform drug discovery and development.
Qinecsa's New Powerhouse Executive Team
Qinecsa is proud to welcome our new executive team members, who bring exceptional leadership and deep expertise in the pharmacovigilance industry. Their knowledge and vision will be instrumental in driving innovation and strengthening our commitment to delivering excellence. We look forward to their contributions as we continue to advance patient safety and shape the future of pharmacovigilance. Learn more
Thank you for being a part of the Qinecsa community. We look forward to keeping you informed and engaged!
We’d love to hear from you! Share your thoughts and feedback at [email protected]